Stock Taper
SCREENER COMPARE ANY 2 STOCKS
IRMD
IRADIMED CORPORATION
NASDAQ
$87.85
▲ UP 1.35% (1.17)

KEY STATISTICS

Market Cap$1.12 B
52w High$107.90
52w Low$67.84
Dividend Yield1.40%
FrequencyQuarterly
P/E44.15
Volume76.18K
Shares Out.12.78M

COMPANY

LEADERSHIP

Roger E. Susi
CHIEF EXECUTIVE
Roger E. Susi

COMPENSATION 2026

Salary$385,598
Stock Awards$0
Incentive Plan Pay$395,000
All Other Comp.$0
Total$780,598

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 16, 2014
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
166

PRICE TARGET

Target High$120.00
Target Low$60.00
Target Median$120.00
Target Consensus$100.00

UPCOMING EARNINGS

DateNov 2, 2026
DayMonday
Rev. Est.$23.20M
NOV
2
MON

PRICE

$87.85 ▲ UP 1.35% (+$1.17)
$86.50$87.00$87.50$88.009:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM87.85

About IRadimed Corporation

https://www.iradimed.com ↗

Iradimed Corporation develops and markets MRI-compatible medical devices, including infusion pumps, vital signs monitors, and accessories, serving healthcare facilities worldwide through direct sales and distributors.

INDUSTRY

Medical - Devices

A PRODUCT IRADIMED CORPORATION IS KNOWN FOR

MRidium® 3870 MRI IV Infusion Pump System
MRidium® 3870 MRI IV Infusion Pump System

IRadimed's FDA-cleared, non-magnetic MRI-compatible infusion pump ensures safe, accurate fluid delivery within MRI environments, representing their next-generation, market-leading solution and key strategic focus.

COMPETITORS

COMPETITOR
BAX COMPARE
BDX COMPARE
GEHC COMPARE
ICUI COMPARE
MDT COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Device Revenue— — $15.39M $13.85M ▼
MRI Compatible Patient Vital Signs Monitoring Systems$6.87M $7.07M ▲$7.11M ▲$6.67M ▼
Service— — $1.04M $1.07M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$18.11M $18.3M ▲$18.02M ▼$16.72M ▼
International$3.09M $4.39M ▲— —
NonUS— — $3.95M $3.75M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
126
LISTED HERE
26
RANKED BY POSITION SIZE
VTS.AX
0.00% · 264.4K
IWM
0.02% · 213.5K
DFMC
0.05% · 44.4K
FYC
0.24% · 39.1K
SCHA
0.01% · 38.3K
FSMD
0.08% · 27.9K
DES
0.12% · 27.4K
XHE
0.98% · 20.0K
PSC
0.07% · 19.5K
AVSC
0.05% · 19.4K
GSSC
0.12% · 14.4K
AI
AIMS
1.09% · 11.0K
XRS2.DE
0.02% · 7.7K
BFOR
0.19% · 4.9K
RSSL
0.02% · 4.0K
OMFS
0.08% · 2.6K
SAWS
2.88% · 2.6K
ROSC
0.35% · 2.3K
SGRW
0.52% · 1.7K
RTWO.L
0.05% · 1.2K
SQLV
0.26% · 1.2K
PQ
PQSG
0.21% · 1.1K
RFLR
0.08% · 855
URTY
0.01% · 345
USUE.DE
0.00% · 30
MFIG
0.02% · 24

INSTITUTIONAL OWNERSHIP

SHARES OWNED
45.10%
HOLDERS
293
TOP 12 OF 293 · RANKED BY POSITION SIZE
Blackrock, Inc.
1.0M sh · $72.29M
Blackrock Inc.
818.3K sh · $35.96M
Nine Ten Capital Management LLC
771.4K sh · $54.89M
Vanguard Group Inc
566.5K sh · $40.31M
Renaissance Technologies LLC
488.8K sh · $34.78M
Copeland Capital Management, LLC
433.5K sh · $30.85M
Kayne Anderson Rudnick Investment Management LLC
397.0K sh · $37.94M
T. Rowe Price Investment Management, Inc.
318.7K sh · $30.45M
Geode Capital Management, LLC
290.1K sh · $27.73M
Dimensional Fund Advisors LP
229.3K sh · $21.91M
State Street Corp
221.5K sh · $21.17M
Goldman Sachs Group Inc
214.2K sh · $20.46M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score3

INSIDER TRADES

★
OFFICER: CFO
GLENN JOHN
Purchase · 5.8K shares
2026-06-20
★
OFFICER: CFO
GLENN JOHN
Sale · 2.3K shares
2026-06-20
★
OFFICER: CFO
GLENN JOHN
Sale · 5.8K shares
2026-06-20
★
DIRECTOR
Scharen-Guivel Hilda Frederique
Sale · 1.8K shares
2026-06-04

SECTORS PEERS

PEERPRICE
AXGN$50.40COMPARE
TNDM$22.32COMPARE
IART$16.74COMPARE
CRON$3.31COMPARE
GDRX$3.45COMPARE
OPK$1.48COMPARE
INMD$15.06COMPARE
AHCO$5.63COMPARE